<DOC>
	<DOCNO>NCT01344733</DOCNO>
	<brief_summary>The study detect hypomanic symptom treatment resistant MDD patient mean HCL-32 administration . Further re-evaluation MDD diagnosis direct aim study . No efficacy tolerability pharmacological treatment assess . Patients match inclusion exclusion criterion enrol consecutively ; investigator include first 10 40 patient visited treatment resistant MDD .</brief_summary>
	<brief_title>A Non Interventional Study Investigating Ratio Mis-diagnosed Bipolar Symptoms Patient With Major Depressive Disorder ( MDD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Written inform consent form Male Female age : 1865 year Diagnosis MDD accord DSMIV TR ( 296.3 x Major Depressive Disorder , recurrent ) Treatment resistance define nonresponse least 2 antidepressant give ade Patients already participate clinical trial interventional study Patients unable understand HCL32 item meaning</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>MDD</keyword>
</DOC>